Deepinder Goyal’s Temple acquires London longevity clinic Longevous ahead of wearable launch

Temple, the health-tech startup founded by Deepinder Goyal, has acquired London-based Longevous to add clinical and scientific expertise as it prepares to launch a wearable designed to track cerebral blood flow and oxygenation.

— Source publishedThu, 27 Aug, 2026, 17:43 IST·First seen Thu, 27 Aug, 2026, 17:45 IST·Source Mint

What happened

Deepinder Goyal-founded health-tech startup Temple acquired London longevity clinic Longevous to add clinical and scientific capabilities before launching its

Key facts

  • Nearly 20 years of clinical experience
  • Around two months of daily device use

Why this matters

Longevous gives Temple scientific talent and clinical infrastructure that could accelerate validation, regulatory readiness, and go-to-market differentiation for its wearable.

What to watch

  • Announcement of product specifications, launch timing, price and whether a recurring subscription is attached.
  • Published validation data, peer-reviewed research or clinical trial registrations involving Temple's sensor technology.
  • UK, India, US or EU medical-device filings and the precise language used in marketing claims.
  • Expansion of Longevous clinic locations, employer-health partnerships or diagnostic-lab alliances.
  • Hiring of regulatory, clinical research, hardware manufacturing and consumer-retail leadership.
  • Partnerships with insurers, hospital systems, premium gyms or pharmacy/health retailers.
  • Integrate Longevous clinicians and protocols into Temple's product-development, data-governance and claims-review processes.
  • Run prospective studies comparing wearable readings with clinical-grade blood-flow and oxygenation measurements.
  • Launch a limited cohort through Longevous and partner clinics before broader direct-to-consumer distribution.
  • Bundle device access with paid interpretation, longevity consultations and personalized health programs.
  • Pursue medical-device clearances selectively while initially constraining consumer messaging to wellness-oriented use cases.

Also reported by